We are live on ! Find out more
ANVS icon

Annovis Bio
ANVS

23 hedge funds and large institutions have $9.6M invested in Annovis Bio in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.04% more ownership

Funds ownership: 9.04% → 9.08% (+0.04%)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

4% less capital invested

Capital invested by funds: $10M → $9.6M (-$441K)

8% less funds holding

Funds holding: 25 → 23 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RAM
Redmond Asset Management
Virginia
+$425K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$311K
3
MFG
Merit Financial Group
Georgia
+$289K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$15.8K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.38K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$516K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$162K
3
KCM
Knoll Capital Management
Florida
-$147K
4
Morgan Stanley
Morgan Stanley
New York
-$145K
5
Bank of America
Bank of America
North Carolina
-$11.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.26M +$1.38K +110 +0%
BlackRock
2
BlackRock
New York
$1.39M -$516K -41,253 -29%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$584K +$15.8K +1,262 +3%
MFG
4
Merit Financial Group
Georgia
$580K +$289K +23,150 +116%
WFAG
5
Wescott Financial Advisory Group
Pennsylvania
$559K – – –
Bank of New York Mellon
6
Bank of New York Mellon
New York
$460K -$1.32K -106 -0.3%
RAM
7
Redmond Asset Management
Virginia
$457K +$425K +34,010 New
SIAP
8
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$436K – – –
MWM
9
Modera Wealth Management
New Jersey
$410K – – –
Morgan Stanley
10
Morgan Stanley
New York
$398K -$145K -11,631 -28%
BCM
11
Bridgeway Capital Management
Texas
$317K – – –
State Street
12
State Street
Massachusetts
$230K – – –
CC
13
Cannell & Co
New York
$134K – – –
Koshinski Asset Management
14
Koshinski Asset Management
Illinois
$134K – – –
Wells Fargo
15
Wells Fargo
California
$118K +$13 +1 +0%
Osaic Holdings
16
Osaic Holdings
Arizona
$45K +$1.07K +86 +3%
IA
17
IFP Advisors
Florida
$44K – – –
TRCT
18
Tower Research Capital (TRC)
New York
$21K -$2.06K -165 -10%
Bank of America
19
Bank of America
North Carolina
$14.4K -$11.5K -917 -46%
Rockefeller Capital Management
20
Rockefeller Capital Management
New York
$13K – – –
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$334 +$311K +24,860 New
Citigroup
22
Citigroup
New York
$81 – – –
KCM
23
Knoll Capital Management
Florida
– -$147K -14,210 Closed
Two Sigma Advisers
24
Two Sigma Advisers
New York
– -$162K -11,800 Closed
HNWAG
25
High Net Worth Advisory Group
Florida
– -$3K -200 Closed

ANVS Hedge Fund Activity: Q4 2022 in Review

23 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q4 2022, worth a combined $9.6M — down 4.4% from $10M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ANVS and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 5 added.

The largest buyer was Redmond Asset Management, opening a new position worth an estimated $425K. The largest seller was BlackRock, cutting an estimated $516K.

  • 23 institutional investors held Annovis Bio (ANVS) as of Q4 2022, down from 25 in Q3 2022.
  • Funds reported $9.6M of Annovis Bio stock for Q4 2022, down 4.4% quarter-over-quarter.
  • 2 funds opened new Annovis Bio positions in Q4 2022 and 4 closed out, a net change of -2 holders.
  • The largest Annovis Bio buyer in Q4 2022 was Redmond Asset Management, an estimated $425K added.
  • The largest Annovis Bio seller in Q4 2022 was BlackRock, an estimated $516K sold.

Based on aggregated 13F filings for Q4 2022.